These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10970248)

  • 1. Novel Fosfomycin resistance of Pseudomonas aeruginosa clinical isolates recovered in Japan in 1996.
    Shimizu M; Shigeobu F; Miyakozawa I; Nakamura A; Suzuki M; Mizukoshi S; O'Hara K; Sawai T
    Antimicrob Agents Chemother; 2000 Jul; 44(7):2007-8. PubMed ID: 10970248
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic effects of fosfomycin and carbapenems against carbapenem-resistant Pseudomonas aeruginosa clinical isolates.
    Kunakonvichaya B; Thirapanmethee K; Khuntayaporn P; Montakantikul P; Chomnawang MT
    Int J Antimicrob Agents; 2015 May; 45(5):556-7. PubMed ID: 25724628
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of erythromycin and fosfomycin on Pseudomonas aeruginosa biofilm in vitro].
    Xu Z; Liu F; Wang X
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):342-4. PubMed ID: 11802985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
    Tessier F; Quentin C
    Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa.
    Walsh CC; McIntosh MP; Peleg AY; Kirkpatrick CM; Bergen PJ
    J Antimicrob Chemother; 2015 Nov; 70(11):3042-50. PubMed ID: 26209311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics.
    Watine J; Bourrel C; Dubourdieu B; Gineston JL; Bories P; Durand M; Marre A; Formosa F; Brunel MP; Palliez J
    Pathol Biol (Paris); 1994 Apr; 42(4):293-5. PubMed ID: 7808781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of fosfomycin against multidrug-resistant Pseudomonas aeruginosa in vitro.
    Kobayashi Y; Sumitani Y; Sugita K; Aikawa N
    Int J Antimicrob Agents; 2007 Dec; 30(6):563-4. PubMed ID: 17900870
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
    Ullmann U; Lindemann B
    Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of carbapenem resistant Ps. aeruginosa, isolates carrying ESBLs, AmpC and MBL enzymes based on phenotypic methodology and susceptibility to Fosfomycin.
    Garg R; Gupta V; Chander J; Kaur M
    Indian J Med Microbiol; 2015 Feb; 33 Suppl():160-1. PubMed ID: 25657141
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance.
    Walsh CC; Landersdorfer CB; McIntosh MP; Peleg AY; Hirsch EB; Kirkpatrick CM; Bergen PJ
    J Antimicrob Chemother; 2016 Aug; 71(8):2218-29. PubMed ID: 27118778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of 2 automated microdilution techniques compared to an agar dilution method in determining sensitivity to fosfomycin in strains of carbapenem-resistant Pseudomonas aeruginosa].
    Gil-Romero Y; Regodón-Domínguez M; Wilhelmi de Cal I; López-Fabal F; Gómez-Garcés JL
    Enferm Infecc Microbiol Clin; 2016; 34(7):406-8. PubMed ID: 26620604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P; Tunyapanit W
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between sensitivity to fosfomycin and the presence of penicillinase PSE-1 in Pseudomonas aeruginosa].
    Hance P; Fabre R; Leblanc F; Cavallo JD
    Pathol Biol (Paris); 2001 Feb; 49(1):12-5. PubMed ID: 11265218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic Attainment of the Synergism of Meropenem and Fosfomycin Combination against Pseudomonas aeruginosa Producing Metallo-β-Lactamase.
    Albiero J; Mazucheli J; Barros JPDR; Szczerepa MMDA; Nishiyama SAB; Carrara-Marroni FE; Sy S; Fidler M; Sy SKB; Tognim MCB
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is a New Standard Needed for Diffusion Methods for In Vitro Susceptibility Testing of Fosfomycin against Pseudomonas aeruginosa?
    Díez-Aguilar M; Martínez-García L; Cantón R; Morosini MI
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1158-61. PubMed ID: 26643341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic activities of combinations of beta-lactams, fosfomycin, and tobramycin against Pseudomonas aeruginosa.
    Takahashi K; Kanno H
    Antimicrob Agents Chemother; 1984 Nov; 26(5):789-91. PubMed ID: 6440482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model.
    Drusano GL; Neely MN; Yamada WM; Duncanson B; Brown D; Maynard M; Vicchiarelli M; Louie A
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sensitivity to fosfomycin of multiresistant serotype 012 Pseudomonas aeruginosa. Multicenter study].
    Dubrous P; Cavallo JD; Buisson Y
    Pathol Biol (Paris); 1997 Jun; 45(6):472-8. PubMed ID: 9309262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism between fosfomycin and nalidixic acid in vitro.
    Ullmann U
    J Antimicrob Chemother; 1979 Sep; 5(5):612-3. PubMed ID: 115834
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vitro activity of fosfomycin, alone or in combination, against clinical isolates of carbapenem resistant Pseudomonas aeruginosa].
    Gómez-Garcés JL; Gil-Romero Y; Sanz-Rodríguez N; Muñoz-Paraíso C; Regodón-Domínguez M
    Enferm Infecc Microbiol Clin; 2016 Apr; 34(4):228-31. PubMed ID: 26277206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.